Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center Lymphoma.
Schrader AMR, de Groen RAL, Willemze R, Jansen PM, Quint KD, van Wezel T, van Eijk R, Ruano D, Tensen CP, Diepstra A, van den Berg A, Koens L, Kakiailatu N, Vermeer MH, Vermaat JSP. Schrader AMR, et al. Among authors: vermaat jsp. Am J Surg Pathol. 2025 Jun 13. doi: 10.1097/PAS.0000000000002436. Online ahead of print. Am J Surg Pathol. 2025. PMID: 40511879
MATRix and HD-MTX/IFO/DEP treatment and autologous stem cell transplantation in secondary central nervous system lymphoma: a Dutch retrospective analysis.
De Groot FA, Stedema FG, Kret EJ, De Haan LM, Jansen PM, Böhringer S, Diepstra A, Van der Poel MWM, Hamid MA, Te Boome LCJ, Terpstra V, Brink M, Veelken H, De Groen RAL, Dekker TJA, Nijland M, Vermaat JSP. De Groot FA, et al. Among authors: vermaat jsp. Haematologica. 2025 May 29. doi: 10.3324/haematol.2025.287485. Online ahead of print. Haematologica. 2025. PMID: 40438976 Free article.
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up.
d'Amore F, Federico M, de Leval L, Ellin F, Hermine O, Kim WS, Lemonnier F, Vermaat JSP, Wulf G, Buske C, Dreyling M, Jerkeman M; ESMO Guidelines Committees. Electronic address: clinicalguidelines@esmo.org; EHA Guidelines Committees. Electronic address: guidelines@ehaweb.org. d'Amore F, et al. Among authors: vermaat jsp. Ann Oncol. 2025 Jun;36(6):626-644. doi: 10.1016/j.annonc.2025.01.023. Epub 2025 May 8. Ann Oncol. 2025. PMID: 40345949 No abstract available.
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up.
d'Amore F, Federico M, de Leval L, Ellin F, Hermine O, Kim WS, Lemonnier F, Vermaat JSP, Wulf G, Buske C, Dreyling M, Jerkeman M; ESMO and EHA Guidelines Committees. d'Amore F, et al. Among authors: vermaat jsp. Hemasphere. 2025 May 7;9(5):e70128. doi: 10.1002/hem3.70128. eCollection 2025 May. Hemasphere. 2025. PMID: 40342876 Free PMC article. No abstract available.
Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment.
de Groen RAL, de Groot FA, Böhringer S, Kret EJ, de Haan LM, Noordenbos T, Blommers S, Jansen REW, van Wezel T, van Eijk R, Raghoo R, Ruano D, Boome LT, Terpstra V, Levenga H, Ahsmann E, Posthuma EFM, Focke-Snieders I, Hardi L, den Hartog WCE, van den Berg A, Mutsaers P, Lam K, van der Poel MWM, Hamid MA, Woei-A-Jin FJSH, Janssens A, Tousseyn T, Bovée JVMG, Koens L, Diepstra A, Cleven AHG, Kersten MJ, Jansen PM, Veelken H, Nijland M, Dekker TJA, Vermaat JSP. de Groen RAL, et al. Among authors: vermaat jsp. Blood Cancer J. 2025 Apr 29;15(1):82. doi: 10.1038/s41408-025-01291-z. Blood Cancer J. 2025. PMID: 40301298 Free PMC article.
Atezolizumab Consolidation in Patients with High Risk Diffuse Large B-cell Lymphoma in Complete Remission after R-CHOP.
Nijland M, Issa DE, Bult JAA, Deeren D, Velders GA, Nijziel MR, Sandberg Y, Vergote VK, Oosterveld M, Fijnheer R, Brouwer R, Boersma R, Wu K, Nieuwenhuizen L, Vermaat JS, van Kampen RJW, Terpstra WE, Snauwaert S, van der Poel MW, de Jongh E, Durian M, Strobbe L, Beeker A, Gadisseur AP, Van Rijn R, Visser OJ, Doorduijn J, Snijders TJF, Silbermann MH, de Jong D, Chamuleau MED, Mous R, Jalving M, Visser-Wisselaar H, Jansen van den Bergh S, Zwezerijnen GJ, Bremer E, Brink M, Diepstra A, Chitu DA, Koene HR, Zijlstra JM. Nijland M, et al. Among authors: vermaat js. Blood Adv. 2025 Apr 18:bloodadvances.2024015226. doi: 10.1182/bloodadvances.2024015226. Online ahead of print. Blood Adv. 2025. PMID: 40249860
Therapy for MYD88 L265P DLBCL.
Vermaat JSP, de Groen RAL. Vermaat JSP, et al. Blood. 2025 Mar 6;145(10):998-1000. doi: 10.1182/blood.2024027538. Blood. 2025. PMID: 40048229 No abstract available.
Enteropathy-associated T-cell lymphoma: A population-based cohort study on incidence, treatment, and outcome in the Netherlands.
Meeuwes FO, Brink M, Plattel WJ, Vermaat JSP, Kersten MJ, Wondergem M, Visser O, van der Poel MWM, Oostvogels R, Woei-A-Jin FJSH, Böhmer L, Snijders TJF, Huls GA, Nijland M. Meeuwes FO, et al. Among authors: vermaat jsp. EJHaem. 2024 Nov 29;5(6):1215-1222. doi: 10.1002/jha2.1049. eCollection 2024 Dec. EJHaem. 2024. PMID: 39691269 Free PMC article.
75 results